According to PerkinElmer 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.30559. At the end of 2023 the company had a P/S ratio of 5.05.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.05 | 12.47% |
2022 | 4.49 | -10.27% |
2021 | 5.01 | 17.88% |
2020 | 4.25 | 13.51% |
2019 | 3.74 | 19.67% |
2018 | 3.13 | -12.43% |
2017 | 3.57 | 39.16% |
2016 | 2.57 | -3.18% |
2015 | 2.65 | 20.62% |
2014 | 2.20 | 2.51% |
2013 | 2.14 | 24.18% |
2012 | 1.73 | 46.64% |
2011 | 1.18 | -28.47% |
2010 | 1.65 | 24.05% |
2009 | 1.33 | 56.45% |
2008 | 0.8479 | -50.46% |
2007 | 1.71 | -3.39% |
2006 | 1.77 | -8.85% |
2005 | 1.94 | 13.05% |
2004 | 1.72 | 21.85% |
2003 | 1.41 | 92.49% |
2002 | 0.7331 | -69.63% |
2001 | 2.41 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | 4.46 | 3.60% | ๐บ๐ธ USA |
![]() Agilent Technologies A | 4.69 | 8.82% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | 4.00 | -7.05% | ๐บ๐ธ USA |
![]() Illumina ILMN | 4.70 | 9.08% | ๐บ๐ธ USA |
![]() Waters Corporation WAT | 5.44 | 26.31% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
![]() Bruker BRKR | 3.38 | -21.56% | ๐บ๐ธ USA |
![]() Bio-Rad Laboratories BIO | 3.78 | -12.13% | ๐บ๐ธ USA |